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Uterine ﬁbroids (leiomyomas, myomas) are the most common
benign tumors of the uteruswith a varietyof symptoms and signs [1].
To diagnose the uterine myoma, ultrasound is always considered as
the ﬁrst-line because of its cost-effectiveness and reliability. When
womenhave atypical symptomsor signs, bizarre image features, and/
or unusual location [2e4], it is not always easy to make an accurate
diagnosis. We reported a case which showed a diagnostic challenge.
A 42-year-oldwoman, with an obstetrics history of gravida 2, para
2, Cesarean section twice, complained of urinary frequency for 6
months. The patient was told to have a small uterine leiomyoma
located on the lower segment of the anterior uterine wall when Ce-
sarean section was performed 11 years previously. She subsequently
received regular follow-up and results were uneventful before the
current examination. Physical examination revealed a bulging mass
in the pelvis. Transvaginal ultrasound showed it as an 8-cm hyper-
vascular cystic mass lesion. Computer tomography (CT) disclosed a
mixed solid and cystic lesionmeasured as 7.4cm 10.1 cm in size rich
with blood ﬂow, favoring ovarian origin (Figure 1). Other laboratory
examinations, including tumor markers, such as CA 125, biochem-
istry, whole blood counts were within the normal limit.
We performed exploratory laparotomy through the previous
scar and identiﬁed a 10-cm cystic lesion, which occupied the
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and the intact tumor was completely removed (Figure 2). The cer-
vix was partially resected and the cervical cannel was exposed. The
defect of cervix was carefully repaired and the abdominal wall was
closed as usual. Postoperative recovery was smooth.
The cut surface of tumor was gray tan appearance (Figure 3).
Histology showed a picture of leiomyoma, which was composed of
interlacing bundles of neoplastic smooth muscle cells with mod-
erate cellularity and rare mitotic ﬁgures. Areas with marked cystic
and myxoid degeneration were noted. Endocervical glands were
noted at the periphery of leiomyoma.
To report this case, we used the term “myxoid degeneration,
leiomyoma, cervix” (from 1956 to December 29, 2015) to search
PubMed for relevant English-language articles (http://www.ncbi.
nlm.nih.gov/pubmed/?term¼myxoidþdegeneration%2Cþleiomyo
ma%2Cþcervix), and identiﬁed only two published articles [5,6].
This report created a diagnostic challenge, and myoma variants are
worthy of our attention.
Cervical myomas can lead to urinary retention, urinary frequency,
constipation, sometimes, menstrual abnormality, dyspareunia, and
postcoital bleeding [5]. Similar to uterine ﬁbroids, myoma variants can
be found in the cervix. As myoma variants are rare, it is undoubted
that myoma variants of the cervix are extremely rare. Arieo et al [7]
suggested three variant-subcategories, including: (1) ordinary
leiomyomas-benign, such as nondegenerated, degenerated (cystic,
hemorrhagic [carneous], fatty [lipoleiomyoma], hyaline, and myxoids);
(2) leiomyoma variants-in between (mitotically active, cellular, atyp-
ical, smooth muscle tumors of uncertain malignant potential [STUMP];
and (3) leiomyosarcoma-malignant [7]. Furthermore, according to
tumor behavior, classiﬁcation can be further separated into two cat-
egories, including little or no recurrent and/or metastatic potential and
recurrent and/or metastatic potential [8]. The former includes myoma
with bizarre nuclei (atypical myoma), mitotically active, cellular, dis-
secting, cotelydonoid, myxoid, epitheloid and diffuse myomas and the
latter (with recurrent and/or metastatic potential) includes smooth
muscle tumor of uncertain malignant potential (STUMP), intravenous,
and benign metastasizing myomas [8].y Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Figure 1. Computed tomography of uterine mass. Contrast-enhanced computed to-
mography shows a large oval hypogenous mass prior to the uterus with an irregular
isodence and heterogeneous enhancement (asterisk) before the cervix. (The cervical
cannel is shown by arrow).
Figure 2. The cystic structure with prominent vessels covering the outer surface. The
cut end from the cervix is shown (arrow).
Figure 3. The cut surface shows gray tan appearance with clear ﬂuid accumulation
within the tumor. Massive myxoid degeneration is shown (arrow).
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available for these clinical uncertainties? First of all, elevated serum
levels of tumor markers might hint at the possibility of malignancy.
Tumor markers are often within the normal limit in patients with
pure leiomyoma, even in cases of degeneration. Magnetic reso-
nance imaging (MRI) might be a better tool for uterine un-
certainties. In T1-weighted images, isointense appears in cystic and
hyaline degeneration; area of high T1 signal intensity appears in
hemorrhagic degeneration; moderate T1 signal intensity, which
suppresses on fat-saturated sequence is found in fatty degenera-
tion, and hypointense appears in myxoid degeneration [7]. In T2-
weighted images, hypointense appears in hyaline degeneration;
moderate andmoderate-to-high T2 signal intensity appears in fatty
and hemorrhagic degeneration; internal areas of high T2 signal
intensity is noted in cystic degeneration; and peripheral high T2
signal intensity appears in myxoid degeneration [7]. In venous
contrast-enhanced MRI, laminated appearance is a typical ﬁnding
in myxoid degeneration; decreased enhancement compared with
ordinary myoma can be found in hyaline degeneration; and with
corresponding areas of nonenhancement is specially found in cystic
degeneration [7]. However, imaging modalities might not be sen-
sitive and/or speciﬁc to distinguish between myxoid myomas and
myxoid leiomyosarcoma [5]. Whole-body positron emission to-
mography/computed tomography (PET/CT) with (18F)-2-
deoxyglucose (FDG) is increasingly being used for disease staging
and restaging and for monitoring treatment of patients with
various cancers; however, FDG can accumulate in normal tissue,
benign lesions, and tissue affected by inﬂammatory processes
[9,10]. Degenerated leiomyomas showing high signal intensity on
T2-weighted MRI tend to show higher FDG uptake than non-
degenerated leiomyoma, suggesting the limited value of PET/CT in
our current reported case.
As shown in the current case, much remains to be learned
clinically, especially for those myoma variants and at the present
time, the diagnosis of these myoma variants cannot be made with
certainty until a pathologist thoroughly examines the specimen [5].
Careful and thorough history taking and appropriate diagnostic
tools might provide a better preparation for these women with
myoma variants.
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